Leorah Walsh
Psychiatry · Bala Cynwyd, PANPI 1245543784
Payments from drug & device makers
Across 137 payments — averaging $21.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$665
- Otsuka America Pharmaceutical, Inc.$310
- Neurocrine Biosciences, Inc.$258
- Takeda Pharmaceuticals U.S.A., Inc.$187
- Eisai Inc.$173
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$158
- plus $1K from 21 others
What the payments were for
- Food & beverage$2,892100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$2,892 in reported general payments places this provider in the 85th percentile of 1,838 psychiatry providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Seroquel XrQuetiapine Fumarate | 18 | $7,434 |
| Escitalopram Oxalate | 14 | $68 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Bala Cynwyd
- Cherian VergheseNorristown$16.3M
- Steven ArnoldPhiladelphia$4.1M
- Paul GrossAllentown$4.1M
- Shivkumar HattiMedia$4M
- Rebecca RomaPittsburgh$3.3M
- Matthew BergerMoosic$2.4M
- Michael ThasePhiladelphia$2.2M
- Robert NelsonWyomissing$2.2M
- Mark MattaNew Castle$847K
- Mayer AyyashPittsburgh$714K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.